Archive for the ‘Cervical Cancer / HPV Vaccine’ Category
Saturday, March 8th, 2008
A comprehensive prevention strategy for reducing the threat of cervical cancer has been called for by the World Medical Association and the Medical Women's International Association. In a joint statement to mark international women's day tomorrow, the two organisations demand ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Friday, March 7th, 2008
Cervical cancer remains a leading killer of women, however, thanks to a test for the human papillomavirus (HPV), the leading cause of cervical cancer, and the development of an HPV vaccine, tools exist to conquer this disease. Cervical cancer is in the public eye and tops public policy agendas, and ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Saturday, March 1st, 2008
The following highlights recent state news about women's health-related legislation. Missouri: The Senate preliminarily approved a bill (SB 778) Tuesday that would require parents of girls entering the sixth grade be sent information on how HPV is transmitted, the virus' symptoms and its link to cervical cancer, as well as ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Tuesday, February 26th, 2008
The New York Times on Sunday examined the possibility of providing human papillomavirus vaccines to boys in an effort to reduce cervical cancer rates. According to the Times, Merck will submit data to FDA this year seeking approval for its HPV vaccine Gardasil to be administered to boys. Gardasil is ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Thursday, February 21st, 2008
Despite growing awareness of HPV (human papillomavirus), the primary cause of cervical cancer, a new survey released by the National Association of Nurse Practitioners in Women's Health (NPWH) found that many women remain in the dark about what it takes to prevent the disease. Despite the fact that there ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Thursday, February 21st, 2008
The following highlights recent state and local news about women's health policy and legislation. Arizona: On Wednesday, the House Health Committee approved 5-4 a measure (HB 2769) that would "essentially mirror" the federal ban (S 3) on so-called "partial-birth" abortion, an antiabortion lobbyist who helped draft the measure said, the ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Monday, February 18th, 2008
The question of whether it is appropriate to vaccinate older women against Human papillomavirus (HPV) is presented for debate in the latest issue of the Medical Journal of Australia. Dr Rachel Skinner - Senior Lecturer at the School of Paediatrics and Child Health at the University of Western Australia - ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Thursday, February 14th, 2008
The following highlights recent news about programs related to human papillomavirus vaccines and sex education.HPV Kentucky: The House Health and Welfare Committee voted 9-5 Thursday to approve a bill (HB 396) that would require girls in public and private middle schools to receive an HPV vaccination, the Louisville Courier-Journal reports ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Tuesday, February 12th, 2008
GlaxoSmithKline CEO Jean-Pierre Garnier on Thursday said that the company will provide FDA with updated information about its human papillomavirus vaccine Cervarix by the third quarter of 2008, Reuters reports. Garnier said that it is not possible to determine whether Cervarix -- which is available in Europe -- will become ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Friday, February 8th, 2008
CytoCore Inc. (OTCBB:CYOE), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, announced that the U.S. Food and Drug Administration has approved the company's 510(k) submission to sell CytoCore's SoftPAP™ cervical cell collector. The SoftPAP collects more comprehensive and complete cervical cell specimens for ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Friday, February 8th, 2008
Merck's human papillomavirus vaccine Gardasil sustained 98% to 100% efficacy in preventing precancerous lesions and preventing cervical cancer, according to a combined analysis of four Phase II and Phase III clinical trials, Reuters reports. The analysis -- presented at the 19th International Congress on Anti-Cancer Treatment in Paris -- involved ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Thursday, February 7th, 2008
CytoCore Inc. (OTCBB:CYOE), the biopharmaceutical research and medical device company for early detection and treatment of reproductive-tract cancers, announced that the U.S. Food and Drug Administration has approved the company's 510(k) submission to sell CytoCore's SoftPAP™ cervical cell collector. The SoftPAP collects more comprehensive and complete cervical cell specimens for ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Wednesday, February 6th, 2008
The following highlights recent news of state actions on women's health.AbortionTennessee: The Senate on Wednesday voted 23-9 to approve a joint resolution (SJR 127) that would amend the state constitution to say that it does not guarantee the right to abortion or require funding for abortion, the Tennessean reports (Johnson, ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Friday, February 1st, 2008
The recent finding that the risk of developing ovarian cancer declines the longer a woman takes oral contraceptives is "worth celebrating, partly because health claims about the pill are often much harder to parse," Slate columnist Amanda Schaffer writes in an opinion piece (Schaffer, Slate, 1/29).For the study on ovarian ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
Wednesday, January 30th, 2008
HiFi DNA Tech has filed suit against the U.S. Food and Drug Administration here in U.S. Federal District Court requesting the high court overturn the FDA's denial of HiFi's petition for reclassification of its human papillomavirus (HPV) DNA detection device from the more-restrictive class III to class II. "The FDA ...
Posted in Cervical Cancer / HPV Vaccine | No Comments »
